Recent 8-K filings for IBAC
Highest-materiality recent filing
IB Acquisition Corp. enters into $500M business combination with GNQ Insilico Inc.
- Total arrangement consideration of $500M plus potential revenue and share-price earnouts.
- GNQ shareholders to receive SPAC Class A common or exchangeable shares; GNQ management to lead combined company.
-
IB Acquisition Corp. extends deadline to complete business combination to September 28, 2026
Stockholders approved extension at special meeting on March 25, 2026.
-
IB Acquisition shareholders approve extension to Sept 28, 2026; ~$7.9M redeemed from trust
All three proposals (extension, trust amendment, adjournment) passed with 5,007,821 for, 70,000 against, no abstentions.
-
GNQ Insilico enters collaboration with Fortune 100 tech firm for AI-driven drug discovery
GNQ Insilico signed a Joint Initiative Agreement with a Fortune 100 global technology company.
-
IB Acquisition Corp. enters into $500M business combination with GNQ Insilico Inc.
Total arrangement consideration of $500M plus potential revenue and share-price earnouts.
-
IBAC extends business combination deadline to March 2026; ~$106M redeemed, trust drops to ~$15.8M
Stockholders approved extension from Sept 28, 2025 to March 28, 2026 for initial business combination.
-
IB Acquisition Corp. dismisses UHY, appoints MaloneBailey as auditor
UHY LLP dismissed as independent auditor effective April 22, 2024, after Audit Committee approval.
Materiality & sentiment trend
Max materiality 0.85 · Median 0.78 · Most common event other_material